Skip to main content
. 2015 Jun 18;9(6):e0003850. doi: 10.1371/journal.pntd.0003850

Fig 4. Mortality in MPXV challenged mice.

Fig 4

Vaccinated and control mice were challenged with 2x105 PFU of MPXV 50 days following the initial vaccination with MVA or BoHV-4 vectors A29L (A), M1R (B), B6R (C), or a combination of all 3 vectors (D). Mice were monitored for mortality. N = 5 mice per group.